Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nucleic acid-based therapeutic strategies for modulator-refractory cystic fibrosis-causing variants.

Human molecular genetics·2026
Same author

Investigation of HE4 expression concerning epithelial-mesenchymal transition (EMT) in cystic fibrosis epithelial cells.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same author

Author's Reply to Yang and Wang: "Personalized Medicine in Cystic Fibrosis: Characterization of Eight Rare CFTR Variants in Intestinal Organoids and Cellular Models".

Molecular diagnosis & therapy·2026
Same author

Comparison of the Effect of CFTR Modulators <i>elexacaftor</i>/<i>tezacaftor</i>/<i>ivacaftor</i> and <i>lumacaftor</i>/<i>ivacaftor</i> via Serum Human Epididymis Protein 4 Concentration in <i>p.Phe508del-CFTR</i> Homozygous Cystic Fibrosis Patients.

Journal of clinical medicine·2025
Same author

Personalized Medicine in Cystic Fibrosis: Characterization of Eight Rare CFTR Variants in Intestinal Organoids and Cellular Models.

Molecular diagnosis & therapy·2025
Same author

CFTR ion transport deficiency primes the epithelium for partial epithelial-mesenchymal transition in cystic fibrosis.

Frontiers in pharmacology·2025
Same journal

Hepatic steatosis in adults on CFTR modulators is commonly associated with cardiometabolic criteria consistent with metabolic dysfunction-associated steatotic liver disease.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same journal

Real-time breath metabolomics to assess early response to CFTR modulators in adults with cystic fibrosis: An open-label proof-of-concept study.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same journal

Cystic fibrosis nutrition: Addressing emerging trends following the 2024 ESPEN-ESPGHAN-ECFS guidelines. Expert opinion recommendations.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same journal

Healthcare priorities and needs for LGBTQIA+ people with cystic fibrosis: A concept mapping study.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same journal

Persistence of large P. aeruginosa aggregates despite reduced airway burden in people with cystic fibrosis on CFTR modulator therapy.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same journal

Partnership between cystic fibrosis centres in Europe: The Twinning Project.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
See all related articles

Related Experiment Video

Updated: Dec 29, 2025

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression
08:58

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on: April 18, 2025

957

Microarray analysis in cystic fibrosis.

Paul Galvin1, Luka A Clarke, Sara Harvey

  • 1NMRC, University College Cork, Lee Maltings, Prospect Row, Cork, Ireland. paul.galvin@nmrc.ie

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|October 7, 2004
PubMed
Summary
This summary is machine-generated.

DNA microarrays offer new ways to study cystic fibrosis (CF) by analyzing gene expression and detecting CFTR mutations. This technology could reveal disease mechanisms and improve CF screening and treatment strategies.

More Related Videos

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

11.0K
Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on: October 15, 2017

8.7K

Related Experiment Videos

Last Updated: Dec 29, 2025

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression
08:58

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on: April 18, 2025

957
Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

11.0K
Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on: October 15, 2017

8.7K

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • DNA microarrays are powerful tools for gene expression analysis and genotyping.
  • Cystic Fibrosis (CF) requires advanced methods for understanding disease mechanisms and identifying therapeutic targets.

Purpose of the Study:

  • To explore the use of DNA microarrays for gene expression analysis in CF.
  • To investigate DNA microarrays as a platform for detecting CFTR mutations for CF screening.

Main Methods:

  • Utilizing DNA microarrays for parallel measurement of thousands of gene expression levels.
  • Employing optimized microarray protocols, including primer extension analysis (minisequencing) and electronic hybridization stringency control.

Main Results:

  • DNA microarrays can identify non-CFTR genes that are differentially expressed in CF.
  • Optimized protocols enable the detection of all relevant CFTR mutations on a single DNA microarray.

Conclusions:

  • DNA microarrays provide insights into CF pathophysiology by revealing altered gene expression.
  • This technology presents a novel platform for efficient CFTR mutation detection and CF screening, potentially leading to new therapeutic strategies.